Desloratadine relieves nasal congestion and improves quality‐of‐life in persistent allergic rhinitis

作者
K. Holmberg,André Bernard Tonnel,I. Dreyfus,Petter Olsson,Jean Cougnard,K. Mesbah,Philippe Devillier
出处
期刊:Allergy [Wiley]
卷期号:64 (11): 1663-1670 被引量:27
标识
DOI:10.1111/j.1398-9995.2009.02096.x
摘要

BACKGROUND: Symptoms of allergic rhinitis (AR), particularly nasal congestion, can impair quality-of-life (QoL). However, only a modest correlation exists between these symptoms and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores, suggesting that both be evaluated for a complete assessment of health. METHODS: Subjects with a > or =2-year history of moderate-to-severe AR to dust mite or cat dander were randomized to desloratadine 5 mg/day (n = 293) or placebo/day (n = 291) for 28 days. Primary endpoint was change from baseline in a.m./p.m. nasal congestion score. Secondary outcomes included change from baseline in total nasal symptom score, individual symptom scores and RQLQ scores (completed on days 1, 7, and 28). RESULTS: The Allergic Rhinitis and its Impact on Asthma criteria for persistent allergic rhinitis (PER) were fulfilled by 99% of subjects in the placebo arm. Between-treatment difference in a.m./p.m. nasal congestion score, observed from day 8 onward, significantly favored desloratadine (P = 0.0003). Desloratadine significantly improved a.m./p.m. nasal congestion and RQLQ scores after 1 week and at treatment end (P < 0.05). Improvements in 5 of 7 RQLQ domain scores exceeded the minimal important difference. On days 7 and 28, desloratadine was also significantly superior to placebo in mean change from baseline in a.m./p.m. total nasal symptom score and rhinorrhea score (both P < or = 0.01). Symptomatic benefit was primarily driven by improvement in nasal congestion and rhinorrhea. CONCLUSIONS: Desloratadine 5 mg/day significantly improved symptoms associated with PER, including nasal congestion, and provided significant improvement in QoL after 1 week of treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ww完成签到 ,获得积分10
1秒前
Blue完成签到 ,获得积分10
1秒前
lzx完成签到,获得积分10
1秒前
yu发布了新的文献求助30
1秒前
asdfsdafg发布了新的文献求助10
1秒前
Krystal完成签到,获得积分10
2秒前
Peng小糕完成签到,获得积分10
2秒前
xxk发布了新的文献求助10
2秒前
开心秋天完成签到,获得积分10
2秒前
瓜瓜发布了新的文献求助10
2秒前
2秒前
英吉利25发布了新的文献求助10
2秒前
紧张的幻露完成签到 ,获得积分10
2秒前
LV完成签到,获得积分10
2秒前
2秒前
昱鱼七seven完成签到,获得积分10
3秒前
可达鸭发布了新的文献求助10
3秒前
淡然凤完成签到,获得积分10
3秒前
whhhhhh发布了新的文献求助10
3秒前
XJC完成签到,获得积分10
4秒前
周游普列国完成签到 ,获得积分10
4秒前
皮皮发布了新的文献求助10
4秒前
4秒前
智慧大狗完成签到,获得积分10
4秒前
rigelfalcon完成签到,获得积分10
4秒前
坚定映阳发布了新的文献求助10
5秒前
6秒前
大力荷花发布了新的文献求助10
6秒前
Zuo_qs完成签到,获得积分10
6秒前
李爱国的应助被相思赋予谁采纳,获得10
6秒前
拼搏的夏菡完成签到 ,获得积分10
6秒前
6秒前
ltttttt完成签到,获得积分10
6秒前
梦想完成签到,获得积分10
7秒前
zhangyuqi完成签到,获得积分10
7秒前
搞怪的盛男完成签到,获得积分10
7秒前
7秒前
8秒前
CodeCraft的应助被六六采纳,获得10
8秒前
坚定的千万完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091